NEW YORK (GenomeWeb) – Roche said this week that Ariosa Diagnostics' Harmony noninvasive prenatal test now has in-network status with the four largest national private insurance health plans in the US, increasing its coverage to approximately 200 million covered lives.
A company spokesperson confirmed that the four plans are offered by United Healthcare, Aetna, Cigna, and Anthem.
Roche said the Harmony Prenatal Test is also accessible to patients covered by Medicaid in multiple states, now also including Medi-Cal in California.
"The continued shift toward in-network coverage for the Harmony test is helping to make noninvasive prenatal testing available to more women," said Dave Mullarkey, Ariosa's chief operating officer and lifecycle leader for NIPT, in a statement.
The Harmony test, a blood test available to pregnant women from 10 weeks of gestation, predicts the risk of trisomies 21, 18, and 13 in an fetus. It competes with several other NIPTs, including tests developed by Sequenom, Illumina, and Natera.